Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Jerome who wrote (1757)	7/28/2014 8:27:14 PM
From: Jerome	Respond to of 27100

Just skimming the headlines about a stock can short circuit your evaluation conclusions. When it comes to a new business model or plans for expansion.......company stock charts are all but useless. Take that article about GTAT and their Hyperion Machine. The first models are being tested now. and the first deliveries are expected in 2015. By 2018 they are expected to sell between 200 and 250 machines. ( about ten per state could be sold)...to be used for brain, neck and throat cancer patients, The cost of the machines will be between 5 and 15 million each. Average cost of 10 million each with margins over 50%. A lot of where a company is headed can be determined from a company's web site. But this is a time consuming endeavor. The author of the previously posted article has a price target for GTAT of $87.00 (about 2018).Annual earning of $5.25 a share. Current price is $14.23...... So if you are looking a five bagger,,,this is it. So that's the problem with headline skimming.......a good healthy shovel will bring better results. It would not surprise me to see GE buy the company to get at the Hyperion Machine to be a complement to their other medical machines (MRI's etc). Any opinions by other thread viewers on this Company?????